FilingReader Intelligence

Shanghai RAAS announces progress on share repurchase plan

July 2, 2025 at 05:12 AM UTCBy FilingReader AI

Shanghai RAAS Blood Products (SZSE:002252) announced the progress of its share repurchase plan, initiated following board approval on January 13, 2025. As of June 30, 2025, the company has cumulatively repurchased 50,973,052 shares through a dedicated securities account, representing 0.77% of the total share capital. The repurchase involved prices ranging from a high of CNY7.09 per share to a low of CNY6.62 per share, with a total expenditure of CNY349,006,309.98, excluding transaction costs. The repurchased shares are intended for employee stock ownership plans or equity incentives. The company confirmed that the repurchase activities adhere to its previously disclosed repurchase plan and relevant regulations.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

SZSE:002252Shenzhen Stock Exchange
Pharmaceuticals

News Alerts

Get instant email alerts when Shanghai RAAS Blood Products publishes news

Free account required • Unsubscribe anytime

Filing Activity Timeline

View Complete Filing History →